Dyslipidemia and the risk of end stage renal disease.
Haydar
Ali A
AA
Renal Medicine and Transplantation Department, Guy's Hospital, London, UK.
Goldsmith
David J A
DJ
D002986:Clinical Trials as Topic; D018450:Disease Progression; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D011507:Proteinuria / Q000188:drug therapy
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors